RA CAPITAL MANAGEMENT, L.P.
Q2 2022 13F-HR Holdings
Net value change ($000)
-832,614
(-18.2%)
New positions
14
Sold out positions
22
Turnover %
18.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| VERU | 89,270 | NEW |
| PEPG | 80,750 | NEW |
| DAWN | 65,911 | 109.6% |
| NS Wind Down Co., Inc. | 45,523 | NEW |
| WAVE LIFE SCIENCES LTD | 40,357 | 259.5% |
| NKTX | 32,373 | 50.8% |
| ACRS | 30,064 | 95.9% |
| BELLUS Health Inc. | 24,144 | 34.3% |
| HilleVax, Inc. | 19,237 | NEW |
| ABOS | 7,719 | 20.2% |
Top Reduces (Value $000, Stocks/ETFs)
| ASND | -184,657 | -20.8% |
| CLYM | -70,620 | -64.0% |
| Mirati Therapeutics, Inc. | -60,378 | -100.0% |
| MGNX | -53,773 | -100.0% |
| iTeos Therapeutics, Inc. | -51,151 | -36.0% |
| NVAX | -51,024 | -100.0% |
| GHRS | -39,406 | -44.6% |
| RYTM | -35,900 | -64.0% |
| CNTA | -32,087 | -100.0% |
| ChemoCentryx, Inc. | -28,980 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|